Four-Year Survival Rate After Second Line Conversion Treatment to Hepatic Resection Using Triplet Hepatic Artery Infusion and Intravenous Cetuximab for KRAS WT Unresectable Metastatic Colorectal Cancer (European Trial Optiliv, NCT00852228)
Lévi Francis
◽
Ducreux Michel
◽
Bouchahda Mohamed
◽
Smith Denis
◽
Karaboué Abdoulaye
◽
...
1993 ◽
Vol 23
(1)
◽
pp. 32-34
◽
F. M. Boyle
◽
R. C. Smith
◽
J. A. Levi
2007 ◽
Vol 102
◽
pp. S204
Khushal Afzal
◽
Weizheng W. Wang
2017 ◽
Vol 117
(7)
◽
pp. 965-973
◽
Francis Lévi
◽
◽
Abdoulaye Karaboué
◽
Raphaël Saffroy
◽
Christophe Desterke
◽
...
2016 ◽
Vol 27
(2)
◽
pp. 118-126
◽
Hui Chen
◽
Ji Zhang
◽
Guang Cao
◽
Peng Liu
◽
Haifeng Xu
◽
...
2004 ◽
Vol 27
(4)
◽
pp. 376-383
◽
Richard A. Oberfield
◽
Eric Sampson
◽
Gerald J. Heatley
2014 ◽
Vol 32
(15_suppl)
◽
pp. 3589-3589
◽
Francis Levi
◽
Michel Ducreux
◽
Denis Michel Smith
◽
Mohamed Hebbar
◽
Céline Lepère
◽
...
2016 ◽
Vol 34
(15_suppl)
◽
pp. TPS3629-TPS3629
Chiara Cremolini
◽
Fotios Loupakis
◽
Luca Boni
◽
Sara Lonardi
◽
Vittorina Zagonel
◽
...
Takanori Goi
◽
Takayuki Naruse
◽
Youhei Kimura
◽
Daisuke Fujimoto
◽
Mitsuhiro Morikawa
◽
...
2019 ◽
Vol 8
(5)
◽
pp. 54-54
Marcia Leung
◽
Sepideh Gholami
2014 ◽
Vol 32
(15_suppl)
◽
pp. 3593-3593
Francis Levi
◽
Abdoulaye Karaboué
◽
Raphaël Saffroy
◽
Elodie Peyric
◽
Michel Ducreux
◽
...
Close
Export Citation Format
Close
Share Document
Close